Delivery Order SPE2DB20D7059-SPE2DB25FQFA5
Award Date
4/29/25
Potential Completion Date
4/30/25
Potential Value
$1.3K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of Naloxone HCL 4 mg nasal spray. The contract is a Firm Fixed Price Delivery Order with a ceiling value of $1,197.16 and an ultimate completion date of January 16, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) valued at $999,999,999 with the DLA Troop Support Medical, which serves as a primary vehicle...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $8,702.93, is for the delivery of 4,562,660,833 units of Naloxone HCL 4 mg Nasal Spray. This is a firm fixed-price Delivery Order contract with a period of performance through November 1, 2023. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen holds...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,559.72 firm fixed-price delivery order is for the supply of Naloxone HCL 4 mg nasal spray, a critical medication used to reverse opioid overdoses. The contract has an ultimate completion date of October 29, 2024. AmerisourceBergen holds a large Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,271.05, is for the delivery of 4,562,300 units of Naloxone HCL 4 mg nasal spray. This is a Firm Fixed Price Delivery Order contract that runs through September 26, 2023. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,102.89 firm fixed-price delivery order contract is for the supply of 4 mg naloxone hydrochloride nasal spray. The contract has an ultimate completion date of August 5, 2024 and was awarded on August 2, 2024. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by...
This is a federal contract award by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of NALOXONE HCL 4 MG NASAL SPRAY 2S, with a ceiling value of $1,315.16 and a completion date of November 13, 2024. The contract is a Firm Fixed Price Delivery Order, with no set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a significant Indefinite...
This federal contract award, valued at $1,211.88, was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,566,450,464 units of Naloxone HCL 4 mg Nasal Spray, with an ultimate completion date of November 18, 2024. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,515.16, is for the delivery of 4,567,379,263 units of Naloxone HCL 4 mg Nasal Spray. This is a Firm Fixed Price Delivery Order contract with a completion date of February 26, 2025. The contract is not designated with a set-aside. Amerisourcebergen Drug Corp is the prime contractor, with no major...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The order is for the supply of Naloxone HCL 4 mg nasal spray, with a ceiling value of $16,431.92 and a performance period through April 29, 2025. The contract is a firm fixed-price delivery order, without any set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a substantial Indefinite...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of Naloxone HCL 4 mg nasal spray. The contract is a Delivery Order with a Firm Fixed Price of $2,435.66 and a completion date of May 5, 2023. The contract is not designated as a set-aside and serves as a task order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...